CLEAR intraventricular hemorrhage: More than a glimmer of hope

Stroke

Volumn 42, Issue 11, 2011, Pages 2999-3000

  Mattle, Heinrich P ^a   Raabe, Andreas ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UROKINASE;

ACUTE DISEASE; ARTERY RUPTURE; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DRUG TREATMENT FAILURE; EDITORIAL; HUMAN; HYPERTENSION; MORTALITY; PATIENT CARE; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

BLOOD COAGULATION; CEREBRAL HEMORRHAGE; FEMALE; HUMANS; MALE; THROMBOLYTIC THERAPY; THROMBOSIS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80054983540     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.111.628024     Document Type: Editorial

References (15)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572. (Pubitemid 37430158)
2. Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, et al. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history: the PROGRESS Trial. Stroke. 2004;35:116-121. (Pubitemid 38057603)
3. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Recombinant activated factor VIIi for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785.
4. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-2137. (Pubitemid 351679599)
5. Mayer SA, Davis SM, Skolnick BE, Brun NC, Begtrup K, Broderick JP, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke. 2009; 40:833-840.
6. Hanley DF. Clot lysis: Evaluating accelerated resolution of intraventricular hemorrhage phase III (CLEAR III), NCT00784134. October 31, 2008. ClinicalTrials.gov. Available at: http://clinicaltrials.gov/. Accessed June 15, 2011.
7. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): A randomised trial. Lancet. 2005;365:387-397. (Pubitemid 40179225)
8. Mendelow AD, Gregson BA, Mitchell PM, Murray GD, Rowan EN, Gholkar AR, et al. Surgical Trial in Lobar Intracerebral Haemorrhage (STICH II) Protocol. Trials. 2011;12:124.
9. Hallevi H, Albright KC, Aronowski J, Barreto AD, Martin-Schild S, Khaja AM, et al. Intraventricular hemorrhage: Anatomic relationships and clinical implications. Neurology. 2008;70:848-852. (Pubitemid 351367505)
10. Tuhrim S, Horowitz DR, Sacher M, Godbold JH. Volume of ventricular blood is an important determinant of outcome in supratentorial intracerebral hemorrhage. Crit Care Med. 1999;27:617-621. (Pubitemid 29162685)
11. Naff N, Williams M, Keyl PM, Tuhrim S, Bullock MR, Mayer S, et al. Low-dose recombinant tissue-type plasminogen activator enhances clot resolution in brain hemorrhage: the Intraventricular Hemorrhage Thrombolysis Trial. Stroke. 2011;42:3009-3016.
12. Kilic E, Kilic U, Matter CM, Lüscher TF, Bassetti CL, Hermann DM. Aggravation of focal cerebral ischemia by tissue plasminogen activator is reversed by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor but does not depend on endothelial NO synthase. Stroke. 2005;36: 332-336. (Pubitemid 40170818)
13. Rohde V, Rohde I, Thiex R, Ince A, Jung A, Dückers G, et al. Fibrinolysis therapy achieved with tissue plasminogen activator and aspiration of the liquefied clot after experimental intracerebral hemorrhage: rapid reduction in hematoma volume but intensification of delayed edema formation. J Neurosurg. 2002;97:954-962. (Pubitemid 35222421)
14. Samadani U, Rohde V. A review of stereotaxy and lysis for intracranial hemorrhage. Neurosurg Rev. 2009;32:15-21.
15. Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J et al. Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery. 2004;54:577-583.